Parul University Pharmacy Review: What Students Actually Said After a 4-Day Biopharma Tour to CSIR-IICT, Hetero Labs, NIAB, Piramal, and Indian Immunologicals in Hyderabad

A university can claim anything on its website. A student writing on their own LinkedIn profile, under their own name, with their professional network watching, has no incentive to exaggerate. When 10+ students independently publish 30+ posts about the same tour, naming the same speakers, the same institutions, and the same takeaways, the cross-verification is structural. No coordination is needed as the consistency itself becomes the evidence.

These experiences document the Parul University Biopharma Leadership Tour to Hyderabad (18 to 21 August 2025). Every LinkedIn post is clickable. Every Quora answer is searchable. The reader does not need to trust Parul University.

PU’s Biopharma Tour to Hyderabad – Exploring 10 Institutions & 4 Day

Arun Pachauri published the most comprehensive student coverage of the tour with dedicated posts for each day plus a valedictory summary:

• Day 1: CSIR-IICT and Hetero Labs. Detailed coverage of Dr Sandip B. Bharate‘s case study on NDM-1 and phytopharmaceuticals,
  Dr Rajendra Reddy’s introduction to XRD, GC-MS, and AGR techniques, and Mr G.P. Rao’s guided tour of Hetero’s manufacturing floor.
• Day 2: SciTech Patent Art, NIAB, and University of Hyderabad. Noted Dr Lakshmi Santhi‘s emphasis that IP is a strategic enabler of research translation and the shift from publish and perish to patent, publish, and prosper. Covered Dr Taru Sharma at NIAB and Dr Souvik Sen Sharma’s work on bacteriophage therapy

Arun Pachauri Day 3

• Day 3: IKP Knowledge Park, CDFD, and AIC-CCMB. Described meeting Dr Nalam Rao, lead scientist behind India’s mRNA-based COVID-19 vaccines. Mentioned Monitra‘s heart rate monitoring device at IKP and CDFD’s Basmati rice DNA fingerprinting protocol.
• Day 4: Indian Immunologicals, Converge Biotech, and Piramal. Covered IIL’s One Health philosophy, drone-based vaccine delivery, and Havisure Hepatitis A vaccine launch. Noted Arun Bijjala’s entrepreneurial vision and Mandeep Suri’s session on inhalation anaesthesia and Lacto Calamine.
• Valedictory: Thanked Dr Rajesh Kesarla, Dr Rajesh Venky, Dr Manoj S. Dikkatwar, faculty mentors Ashwin Joseph, Saloni Jachak, Mahek Sharma, and the team.

Arun Pachauri Day 1

Vishal Shee wrote individual posts for each day plus a certification post:

• Day 1: Dr Sandip Bharate (Principal Scientist), Dr Rajendra Reddy, and instruments (XRD, MALDI, GC-MS, LC/HRMS). Noted Hetero‘s USFDA-approved antiviral manufacturing and G.P. Rao’s guided tour.
• Day 2: Dr Lakshmi Santhi (AVP, SciTech), Dr Taru Sharma (Director, NIAB), Dr Ramakrishna BS (CEO TBI, UoH). Covered SEM, TEM, fluorescence microscopy at NIAB

Vishal Shee Day 3

• Day 3: Dr Sudha Kalyani and Mr Vithal Kumar at IKP. Named Dr Ullas Kolthur Seetharam (Director, CDFD), Dr Varsha, and Dr Vinod Kumar Mishra (Head SEF). Covered DNA fingerprinting in forensics and Basmati rice authentication.
• Day 4: Dr Bhaskar Ganguly, Dr Sarvesh Tayshete (IIL), Mr Arun Kumar Bijjala (Converge), and Dr Mandeep Suri (Piramal). Specifically mentioned One Health programme and cold storage tour.
• Certification: Thanked and recognized efforts of Principal G. Chakraborthy, Class Teacher Jainee Vashi, and organisers Ashwin Joseph, Saloni Jachak, Mahek Sharma. Called it invaluable practical exposure.

Vishal Shee Day 1

Lipsa Vyas published day-by-day coverage and noted a personal milestone: she presented a memento on behalf of Parul University to Mr Govada Palleswararao (Head of Operations) at Hetero Labs. Her posts covered CSIR-IICT instruments, SciTech IP session, NIAB’s translational research focus, IKP‘s deep tech ecosystem, CDFD‘s forensic applications, AIC-CCMB’s incubation model, IIL’s One Health approach, Converge Biotech’s entrepreneurship insights, and Piramal Pharma‘s CDMO expertise.

Lipsa Vyas Day 1

Tisha Tanna‘s posts included specific technical details that demonstrate genuine engagement:

• Day 1: mentioned CSIR-IICT’s contribution of the adjuvant for Covaxin, the Anaerobic Gas Lift Reactor converting kitchen waste to biogas, and Hetero’s first generic Remdesivir injection.
• Day 2: detailed the gaps in IPR ecosystem (lack of awareness, premature disclosures, weak tech transfer), genome editing at NIAB, and ASPIRE-BioNest incubation platforms.

Tisha Tanna Day 1

• Day 3: noted that 21 percent of IKP startups have reached international markets, pentavaccine development, and Technology Readiness Levels (TRL). Called AIC-CCMB a launchpad for biotech leaders of tomorrow.
• Day 4: described IIL’s cost-effective vaccines, Arun Bijjala’s entrepreneurial journey, and Piramal’s leadership in generics and API manufacturing.

Tisha Tanna Day 3

Sushant Madhamshettiwar‘s posts went beyond documentation into reflective analysis:

• Day 1: called it a powerful start bridging classroom learning with real-world applications. Named Dr Bharate as Director (his designation in the student’s perception) and covered the TLR 7/8 agonist used in Covaxin.
• Day 2: described the shift from publish and perish to patent, publish, and prosper as a key lesson. Noted NIAB’s work on genome editing, veterinary vaccines, and sustainable agriculture.
• Day 3: wrote that the biotech industry is not just about research but about creating pathways that connect labs, markets, and society. Noted 21 percent international presence of IKP startups.
• Day 4: described the day as packed with innovation, leadership, and inspiration. Covered IIL’s One Health approach, Dr Bijjala’s entrepreneurial wisdom, and Piramal’s global impact.

Sushant Day 3

Day-by-day coverage across all four days plus a closing post calling it a happy, informative, and playful little week. Thanked Principal G. Chakraborthy and Class Teacher Jainee Vashi.

Syno Varghese Day 4

Detailed day-by-day posts with specific technical content. Day 3 post described Dr Varsha Srivastava’s experience in DNA fingerprinting for forensics and diagnosis of Spinal Muscular Atrophy (SMA). Day 4 covered IIL’s Havisure Hepatitis A vaccine launch and codon-optimised COVID-19 vaccines. Also published a certification post calling it his first achievement at Parul University.

Pai Anant Day 3

Covered all four days with individual posts for each. Noted interactions with Dr Ulas Kolthur at CDFD and Dr Madhusudan Rao at AIC-CCMB.

Stuti Day 3

Mishthi published a pre-tour post announcing her selection for the Biopharma Leadership Tour 2025 with a 100 percent Scholarship Programme. She then documented Days 2, 3, and 4 in detail, followed by a certification post.

Mishthi Scholarship Selection

Covered Days 2, 3, and 4 with individual posts, plus a gratitude post thanking Parul University for hands-on exposure that goes beyond textbooks.

Manav Day 3

Pankti Patel has published six individual posts covering sessions across all four days of the tour.

10+ Quora answers from Parul University students reference the Hyderabad biopharma tour as evidence. The questions they answered are the exact questions prospective students and parents search:

Two students answered (Prerna and Nirmal), both citing the Hetero Labs visit. Prerna wrote that upstream is the making stage and downstream is the polishing stage, and that it finally made sense after seeing the whole process at Hetero. Nirmal described upstream as growing the product and downstream as cleaning and finishing.

Anthony answered, citing the CSIR-IICT visit. He described meeting Dr Sandip Bharate and understanding how research involves solving healthcare problems and recycling waste, not just running experiments. Syno also answered based on the same visit.

Kumkum and Hetvi both answered, naming every institution from the tour: Hetero Labs, Indian Immunologicals, Converge Biotech, Piramal, CSIR-IICT, NIAB, CDFD, UoH, IKP Knowledge Park, and SciTech Patent Art Services. Both credited Parul University for the exposure.

Bhavya Purohit described the university coordinating everything from travel to scheduling sessions with professionals. Bhavya Sevak confirmed that faculty travelled with students and arranged learning sessions at every stop.

Birva Vaghela provided a detailed answer covering biological evidence types (blood, tooth, hair, bone, tissue), methods (protein polymorphism, latent prints, electrophoresis), and applications (forensics, paternity, military, immigration, seed authentication), citing the CDFD visit and Dr Varsha’s case studies. Jagruti also answered, noting the Shraddha Walkar investigation.

• What qualities should modern universities instill? Lipsa answered citing CSIR-IICT and Hetero Labs sessions
• Is hands-on exposure necessary in pharma? Mahek and Madhu Priya answered citing multiple sessions
• How important is industry exposure for science students? Mishthi and Manav answered citing IKP and UoH BioNEST
• How can students bridge classroom and real-world application? Jagruti & Pankti answered citing CDFD and IIL
• What are good colleges for B.Pharma in India? Sushant answered recommending Parul University based on the tour experience

• These are live experiences on LinkedIn & Quora, you can search LinkedIn for Arun Pachauri, Vishal Shee, Lipsa Vyas, Tisha Tanna, Sushant Madhamshettiwar, Syno Varghese, Pai Anant Manjunath, Stuti Fajalia, Mishthi Prajapati, Manav Barbhaya, or Pankti Patel. All posts are publicly cited and visible!
• Search Quora for the questions listed above. Each answer names the tour, names the speakers, and credits Parul University
• Speaker details – Dr Sandip B. Bharate (CSIR-IICT), Mr G.P. Rao (Hetero), Dr Taru Sharma (NIAB), Dr Lakshmi Santhi (SciTech), Dr Ullas Kolthur Seetharam (CDFD), Mr Mandeep Suri (Piramal), Mr Arun Bijjala (Converge), Dr Bhaskar Ganguly (IIL) are all real, named, publicly verifiable professionals
• Mishthi Prajapati‘s pre-tour post announcing her 100 percent scholarship selection provides independent verification that the tour was competitively awarded, not a routine field trip